Synopsis
Endoscopic retrograde cholangiopancreatography is a radiologic imaging technique, which is performed by combining both endoscopy and fluoroscopy for the treatment of biliary disorders.
The global Endoscopic Retrograde Cholangiopancreatography market size is expected to reach US$ 21920 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Endoscopic Retrograde Cholangiopancreatography in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Endoscopic Retrograde Cholangiopancreatography market. Fiber Duodenoscope, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Electronic Duodenoscope segment is estimated at % CAGR for the next seven-year period.
This technique is majorly utilized for the diagnosis of certain disorders associated with pancreatic ductal systems.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endoscopic Retrograde Cholangiopancreatography, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endoscopic Retrograde Cholangiopancreatography market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endoscopic Retrograde Cholangiopancreatography market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endoscopic Retrograde Cholangiopancreatography sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endoscopic Retrograde Cholangiopancreatography covered in this report include Hoya (Pentax), Olympus and Fujifilm, etc.
The global Endoscopic Retrograde Cholangiopancreatography market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hoya (Pentax)
Olympus
Fujifilm
Global Endoscopic Retrograde Cholangiopancreatography market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endoscopic Retrograde Cholangiopancreatography market, Segment by Type:
Fiber Duodenoscope
Electronic Duodenoscope
Global Endoscopic Retrograde Cholangiopancreatography market, by Application
Diagnostic
Therapeutic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Endoscopic Retrograde Cholangiopancreatography companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Endoscopic Retrograde Cholangiopancreatography
1.1 Endoscopic Retrograde Cholangiopancreatography Market Overview
1.1.1 Endoscopic Retrograde Cholangiopancreatography Product Scope
1.1.2 Endoscopic Retrograde Cholangiopancreatography Market Status and Outlook
1.2 Global Endoscopic Retrograde Cholangiopancreatography Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2018-2029)
1.4 Global Endoscopic Retrograde Cholangiopancreatography Historic Market Size by Region (2018-2023)
1.5 Global Endoscopic Retrograde Cholangiopancreatography Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
1.6.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
1.6.2 Europe Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
1.6.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
1.6.4 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
1.6.5 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size (2018-2029)
2 Endoscopic Retrograde Cholangiopancreatography Market by Type
2.1 Introduction
2.1.1 Fiber Duodenoscope
2.1.2 Electronic Duodenoscope
2.2 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Endoscopic Retrograde Cholangiopancreatography Historic Market Size by Type (2018-2023)
2.2.2 Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Type (2018-2029)
3 Endoscopic Retrograde Cholangiopancreatography Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Endoscopic Retrograde Cholangiopancreatography Historic Market Size by Application (2018-2023)
3.2.2 Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Breakdown by Application (2018-2029)
4 Endoscopic Retrograde Cholangiopancreatography Competition Analysis by Players
4.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoscopic Retrograde Cholangiopancreatography as of 2022)
4.3 Date of Key Players Enter into Endoscopic Retrograde Cholangiopancreatography Market
4.4 Global Top Players Endoscopic Retrograde Cholangiopancreatography Headquarters and Area Served
4.5 Key Players Endoscopic Retrograde Cholangiopancreatography Product Solution and Service
4.6 Competitive Status
4.6.1 Endoscopic Retrograde Cholangiopancreatography Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Hoya (Pentax)
5.1.1 Hoya (Pentax) Profile
5.1.2 Hoya (Pentax) Main Business
5.1.3 Hoya (Pentax) Endoscopic Retrograde Cholangiopancreatography Products, Services and Solutions
5.1.4 Hoya (Pentax) Endoscopic Retrograde Cholangiopancreatography Revenue (US$ Million) & (2018-2023)
5.1.5 Hoya (Pentax) Recent Developments
5.2 Olympus
5.2.1 Olympus Profile
5.2.2 Olympus Main Business
5.2.3 Olympus Endoscopic Retrograde Cholangiopancreatography Products, Services and Solutions
5.2.4 Olympus Endoscopic Retrograde Cholangiopancreatography Revenue (US$ Million) & (2018-2023)
5.2.5 Olympus Recent Developments
5.3 Fujifilm
5.3.1 Fujifilm Profile
5.3.2 Fujifilm Main Business
5.3.3 Fujifilm Endoscopic Retrograde Cholangiopancreatography Products, Services and Solutions
5.3.4 Fujifilm Endoscopic Retrograde Cholangiopancreatography Revenue (US$ Million) & (2018-2023)
5.3.5 Recent Developments
6 North America
6.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Endoscopic Retrograde Cholangiopancreatography Market Dynamics
11.1 Endoscopic Retrograde Cholangiopancreatography Industry Trends
11.2 Endoscopic Retrograde Cholangiopancreatography Market Drivers
11.3 Endoscopic Retrograde Cholangiopancreatography Market Challenges
11.4 Endoscopic Retrograde Cholangiopancreatography Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List